Nephros Announces Presentations at Five Upcoming Investor Conferences
SOUTH ORANGE, NJ - 
(NewMediaWire) - September 03, 2019 - Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced presentations at five upcoming investor conferences.
Daron Evans, President and Chief Executive Officer, and Andy Astor, Chief Operating and Financial Officer, will provide overviews of Nephros’ business during the conferences and will be available for one-on-one meetings with registered participants. Company information, including the most recent corporate presentation, is available on the Nephros website: https://www.nephros.com/investor-relations/
LD Micro San FranciscoSummit
Date:Tuesday, September 3
Time:8:40am Pacific Time
Location:JW Marriott, San Francisco
Speaker:Daron Evans
For more information: https://www.ldmicro.com
RHK Capital 2019 Disruptive Growth Conference
Date:Wednesday, September 4
Time:2:40pm Eastern Time
Location:Reed Smith, New York, NY
Speaker:Andy Astor
For more information and webcast: http://disruptnyc.com
Fall Investor Summit
Date:Monday, September 16
Time:9:00am Eastern Time
Location:The Essex House, New York, NY
Speaker:Andy Astor
For more information: https://microcapconf.com
MicroCap Leadership Summit
Date:Friday, September 27, 2019
Time:All day
Location:Westin Chicago Northwest Hotel, Itasca, Illinois
Speaker: Andy Astor
For more information: https://microcapclub.com/summit/
LD Micro New York City Summit
Date: Monday, October 7, 2019
Time: 9:00am Eastern Time
Location:Lowenstein Sandler, 1251 6th Ave., New York, NY
Speaker: Andy Astor
For more information: https://www.ldmicro.com/events
About Nephros, Inc.
Nephros is a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets. Nephros ultrafilters are used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist in improving infection control in showers, sinks, and ice machines. Additionally, Nephros ultrafilters are used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients.
Nephros filters, including AETHER™ brand filters, improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Nephros and AETHER™ products are used in the health care, food service, hospitality, and convenience store markets.
For more information about Nephros, please visit our website at www.nephros.com. ww.nephros.com.
Investor Relations Contact:
Kirin Smith, President
PCG Advisory, Inc.
(646) 863-6519
